Home LiteratureArticle Details
PMID: 2183713 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Amphotericin B: current understanding of mechanisms of action.

Antimicrobial agents and chemotherapy ·Vol. 34 ·No. 2 ·1990-02-00 ·Pages 183-8

Brajtburg J, Powderly WG, Kobayashi GS, Medoff G

Abstract

暂无摘要

MeSH Terms
Amphotericin B/pharmacology,therapeutic use Fungi/drug effects
Chemicals
Amphotericin B
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Brajtburg J
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
Powderly W G
Kobayashi G S
Medoff G
References (53)
53 references, click to expand
  1. Sterols from polyene-resistant mutants of Candida albicans.
    J Gen Microbiol. 1972 Nov;73(1):201-3 PMID: 4569578
  2. Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles.
    Biochimie. 1989 Jan;71(1):49-56 PMID: 2497797
  3. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
    Antimicrob Agents Chemother. 1975 Jun;7(6):724-9 PMID: 1155916
  4. Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.
    Am J Med. 1976 Nov;61(5):632-40 PMID: 984066
  5. Eburicol, lichesterol, ergosterol, and obtusifoliol from polyene antibiotic-resistant mutants of Candida albicans.
    Can J Microbiol. 1977 Jun;23(6):751-4 PMID: 326362
  6. Lipid composition and polyene antibiotic resistance of Candida albicans mutants.
    Can J Biochem. 1978 Feb;56(2):135-42 PMID: 343892
  7. Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function.
    Am J Med Sci. 1978 Jul-Aug;276(1):77-92 PMID: 727219
  8. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.
    N Engl J Med. 1979 Jul 19;301(3):126-31 PMID: 449951
  9. Development of resistance to amphotericin B in Candida lusitaniae infecting a human.
    Antimicrob Agents Chemother. 1979 Aug;16(2):123-6 PMID: 290351
  10. Isolation and characterization of a polyene-resistant variant of Candida tropicalis.
    J Clin Microbiol. 1979 Jun;9(6):677-80 PMID: 387815
  11. Classification of polyene antibiotics according to chemical structure and biological effects.
    Antimicrob Agents Chemother. 1979 May;15(5):716-22 PMID: 393163
  12. Incidence of polyene-resistant yeasts recovered from clinical specimens.
    Antimicrob Agents Chemother. 1980 Jul;18(1):158-63 PMID: 7416742
  13. Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes.
    Biochim Biophys Acta. 1980 Nov 4;602(2):260-8 PMID: 7426650
  14. Leukoencephalopathy in patients treated with amphotericin B methyl ester.
    J Infect Dis. 1982 Aug;146(2):125-37 PMID: 7108268
  15. Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study.
    Biochemistry. 1983 Jun 7;22(12):2939-44 PMID: 6871175
  16. Polyene toxicity in renal medulla: injury mediated by transport activity.
    Science. 1984 Apr 6;224(4644):66-8 PMID: 6322305
  17. Haemolytic activity of aromatic heptaenes. A group of polyene macrolide antifungal antibiotics.
    Biochem Pharmacol. 1984 Jan 1;33(1):41-6 PMID: 6704143
  18. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii.
    Ann Intern Med. 1985 Jan;102(1):67-8 PMID: 3966747
  19. Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.
    Antimicrob Agents Chemother. 1984 Dec;26(6):892-7 PMID: 6084471
  20. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
    Antimicrob Agents Chemother. 1985 Feb;27(2):172-6 PMID: 3985601
  21. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.
    J Clin Microbiol. 1985 Apr;21(4):501-4 PMID: 3838757
  22. Mechanism of inactivation of the polyene antibiotic amphotericin B. Evidence for radical formation in the process of autooxidation.
    J Antibiot (Tokyo). 1985 Jun;38(6):753-7 PMID: 2991182
  23. Interaction of the polyene antibiotic etruscomycin with large unilamellar lipid vesicles: binding and proton permeability inducement.
    Biochim Biophys Acta. 1985 Oct 24;820(1):63-73 PMID: 2996598
  24. Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.
    Mol Pharmacol. 1986 Mar;29(3):293-8 PMID: 3951434
  25. Sensitivity of Candida albicans to amphotericin B administered as single or fractionated doses.
    Antimicrob Agents Chemother. 1986 Apr;29(4):701-2 PMID: 3518626
  26. Amphotericin B-induced oxidative damage and killing of Candida albicans.
    J Infect Dis. 1986 Jul;154(1):76-83 PMID: 3519792
  27. B cell triggering properties of a nontoxic derivative of amphotericin B.
    J Immunol. 1986 Oct 1;137(7):2156-61 PMID: 3489754
  28. Nature and development of phenotypic resistance to amphotericin B in Candida albicans.
    Adv Microb Physiol. 1986;27:277-320 PMID: 3532717
  29. Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.
    Infect Immun. 1986 Nov;54(2):303-7 PMID: 3770945
  30. Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
    Cancer Res. 1986 Dec;46(12 Pt 1):6054-8 PMID: 3465432
  31. How do the polyene macrolide antibiotics affect the cellular membrane properties?
    Biochim Biophys Acta. 1986 Dec 22;864(3-4):257-304 PMID: 3539192
  32. Spin-labeled amphotericin B: synthesis, characterization, biological and spectroscopic properties.
    Biochim Biophys Acta. 1987 Mar 12;897(3):467-73 PMID: 3028486
  33. Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains.
    Cell Immunol. 1987 Mar;105(1):99-109 PMID: 3815541
  34. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans.
    J Med Vet Mycol. 1987 Feb;25(1):29-37 PMID: 3553525
  35. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.
    N Engl J Med. 1987 Aug 6;317(6):334-41 PMID: 3299095
  36. In vitro activity of systemic antifungal agents against Malassezia furfur.
    Antimicrob Agents Chemother. 1987 Jun;31(6):951-3 PMID: 3619430
  37. Interaction of 14C-labelled amphotericin B derivatives with human erythrocytes: relationship between binding and induced K+ leak.
    Biochim Biophys Acta. 1988 Feb 8;938(1):97-106 PMID: 3337820
  38. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
    Antimicrob Agents Chemother. 1987 Nov;31(11):1756-60 PMID: 3324961
  39. Antifungal susceptibility tests.
    Antimicrob Agents Chemother. 1987 Dec;31(12):1867-70 PMID: 3326524
  40. Quantitative structure-activity relationships in amphotericin B derivatives.
    Biochem Pharmacol. 1988 Mar 1;37(5):827-36 PMID: 3278711
  41. Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes.
    Biochim Biophys Acta. 1989 Jul 10;982(2):245-52 PMID: 2787669
  42. Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics.
    Eur Biophys J. 1989;17(3):159-66 PMID: 2792025
  43. Effects of ascorbic acid on the antifungal action of amphotericin B.
    J Antimicrob Chemother. 1989 Sep;24(3):333-7 PMID: 2681119
  44. Amphotericin B: delivery systems.
    Antimicrob Agents Chemother. 1990 Mar;34(3):381-4 PMID: 2185689
  45. DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS.
    J Bacteriol. 1965 Jun;89:1533-9 PMID: 14291593
  46. The development of resistance by candida species to polyene antibiotics in vitro.
    J Med Microbiol. 1971 Nov;4(4):505-17 PMID: 5316339
  47. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Proc Natl Acad Sci U S A. 1972 Jan;69(1):196-9 PMID: 4550505
  48. Azole antifungal agents: emphasis on new triazoles.
    Antimicrob Agents Chemother. 1988 Jan;32(1):1-8 PMID: 2831809
  49. Amphotericin B-resistant yeast infection in severely immunocompromised patients.
    Am J Med. 1988 May;84(5):826-32 PMID: 3284339
  50. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.
    Antimicrob Agents Chemother. 1988 May;32(5):702-5 PMID: 3293525
  51. Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granulomatous disease.
    J Clin Invest. 1988 Oct;82(4):1192-201 PMID: 3049672
  52. Treatment of fungal infections with semisynthetic derivatives of amphotericin B alpha.
    Ann N Y Acad Sci. 1988;544:517-46 PMID: 3214091
  53. Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester.
    Antimicrob Agents Chemother. 1975 Jan;7(1):58-63 PMID: 1137359
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1990-02-00
Pages
183-8
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC171553
Subset
IM
Grants
NIAID NIH HHS · AI 16228 · United States
NIAID NIH HHS · AI 25903 · United States
NIAID NIH HHS · N01-AI 72640 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com